Elite Financial Statements From 2010 to 2026
| ELTP Stock | USD 0.50 0.01 2.04% |
Check Elite Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elite Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Elite financial statements analysis is a perfect complement when working with Elite Pharma Valuation or Volatility modules.
Elite |
Elite Pharma OTC Stock Operating Margin Analysis
Elite Pharma's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Elite Pharma Operating Margin | 0.15 % |
Most of Elite Pharma's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elite Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Elite Pharma has an Operating Margin of 0.1455%. This is 100.41% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 102.64% lower than that of the firm.
Elite Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elite Pharma's current stock value. Our valuation model uses many indicators to compare Elite Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elite Pharma competition to find correlations between indicators driving Elite Pharma's intrinsic value. More Info.Elite Pharma is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elite Pharma is roughly 3.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elite Pharma's earnings, one of the primary drivers of an investment's value.About Elite Pharma Financial Statements
Elite Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Elite Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Elite Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Elite Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.